preemptive ketamine in abdominal hystrectomy surgery

Preemptive ketamine in abdominal hysterectomy patients, does the route of adminestration affect analgesia and haemodynamics?? : A prospective randomized controlled trial.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202007562388257

Enrollment

Registered

2020-07-17

Start date

2020-07-08

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

subcutaneous preincisional ketamine injection

intravenous preincisional ketamine injection

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: adult females ASA I or II aging 18-65 years undergoing total abdominal hysterectomy in mansoura university hospital

Exclusion criteria

Exclusion criteria: • Patient refusal • Allergy to used drugs • Addiction • Altered liver or kidney function • Psychological problems. • Complicated procedure

Design outcomes

Primary

Measure	Time frame
pain assessment (VAS score).	—

Secondary

Measure	Time frame
total pethidine intake 24 h, postoperative;nausea , vomiting;HR, MABP, Spo2	—

Countries

Egypt

Contacts

Public Contactmohamed aboelela

lecturer of anaesthesia and SICU

aboelela_mohamed@yahoo.com00201061546753

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026